ADRs:Is the patient voice loud enough? - International Conference London

[Guest guest]

Mid-Year Meeting

International Conference (link to flyer)

ADRs:Is the patient voice loud enough?"

International Conference

Friends House, 173-177 Euston Road,London, NW1 2BJon

Friday 24th June 2011

Programme (link)N.B. we reserve the right to make changes to the programme without notice.

Registration Form (link)

This conference will focus on the role of patients in reporting suspected Adverse Drug Reactions to pharmacovigilance centres. It is the first conference of its kind, bringing together academic researchers and teachers, practitioners, pharmacovigilance experts and patients to learn more about and debate this topic. The conference will highlight what has been learned from studies of the UK Yellow Card Scheme and the work of Lareb in the Netherlands on how patients contribute to reporting of Adverse Drug Reactions and what we can learn from their experiences.

Confirmed Speakers include:

Professor Tony Avery / Professor Janet Krska Evaluation of UK YCS Prof Kees van Grootheest Netherlands Pharmacovigilance Centre Dr Gandhi MHRA Dr Isabelle Moulton European Medicines Agency Professor Simon Maxwell Medical Education

© Prescribing and Research in Medicines Management (UK & Ireland)

Programme

9.30-10.00am

Registration, coffee and assembly of posters

10.00 am Welcome & Introduction: Professor Tony Avery, Nottingham University

10.05 am

Session 1: Direct patient reporting: differing perspectives

Chair: Fleur Fisher, Consultant in Healthcare Ethics

10.20am Professor Tony Avery, Nottingham University

Mrs Lorna Hazell, Drug Safety Research Unit

Professor Janet Krska, Liverpool s University

"Experiences from the UKs Yellow Card Scheme"

10.50 am Professor Kees van Grootheest, Netherlands Pharmacovigilance Centre

"Experiences from Lareb"

11.15- 11.40 am Refreshment break

11.40 am Ms Gandhi, the Medicines and Healthcare Regulatory Agency

"

Patient Reportinga regulatory view"

12.00 pm Dr Isabelle Moulon, European Medicines Agency

"

The role of the EMA and its work with the Patients and Consumers

Organisations"

12.20pm Ms Millie Kieve, Adverse Psychiatric Reactions Information Link

"The patient perspective"

12.50 pm Concluding remarks, preparation for afternoon session

1.00

2.00 pm Lunch, informal poster viewing , submission of questions for

discussion

2.00 pm Session 2: Formal poster presentations Chair: Professor Saad Shakir,

Drug Safety Research Unit, Dr Bryne, University College Cork

2.45

3.05 pm Refreshment break

3.05 pm Session 3: Direct patient reporting: learning lessons

Chair: Liz Else, New Scientist

3.05 pm

Professor Simon Maxwell, University of Edinburgh

"Prescribing in the NHS: looking towards a better future

"

3.25 pm General panel discussion:

Patients experiences of Adverse Drug

Reactions: what can health professionals learn from patients?

4.00 pm Summing up and close of meeting